Lucid Diagnostics Inc (LUCD) PT Raised to $8.25 at Ascendiant Capital

December 10, 2025 3:54 AM EST Send to a Friend
Ascendiant Capital analyst Edward Woo raised the price target on Lucid Diagnostics Inc (NASDAQ: LUCD) to $8.25 (from $8.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login